logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Urinary Bladder Neoplasms

    FiltersReset Filters
    9 results

    • anktiva

      (nogapendekin alfa inbakicept-pmln)
      Altor BioScience, LLC, an indirect wholly-owned subsidiary of ImmunityBio, Inc.
      Usage: ANKTIVA, in combination with Bacillus Calmette-Guérin (BCG), is indicated for treating adult patients with BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS), with or without papillary tumors.

    • cisplatin

      (CISPLATIN)
      Fresenius Kabi USA, LLC
      Usage: Cisplatin Injection is indicated as a single agent for patients with advanced transitional cell bladder cancer that cannot be treated with local therapies, including surgery and radiotherapy.

    • cisplatin

      (Cisplatin)
      Accord Healthcare
      Usage: Cisplatin injection is indicated for the treatment of advanced testicular, ovarian, and bladder cancers.

    • cisplatin

      (Cisplatin)
      BluePoint Laboratories
      Usage: Cisplatin injection is indicated for the treatment of advanced testicular cancer, advanced ovarian cancer, and advanced bladder cancer.

    • cisplatin

      (Cisplatin)
      Teva Parenteral Medicines, Inc.
      Usage: Cisplatin Injection is indicated for the treatment of advanced testicular cancer, advanced ovarian cancer, and advanced bladder cancer.

    • cisplatin

      (CISplatin)
      Apotex Corp.
      Usage: Cisplatin Injection is indicated for use in combination therapy for metastatic testicular and ovarian tumors, post-surgery/radiotherapy. It is also used as a single agent for advanced transitional cell bladder cancer when local treatments are not viable.

    • cysview

      (Hexaminolevulinate hydrochloride)
      Photocure Inc.
      Usage: Cysview is indicated for the cystoscopic detection of bladder carcinoma, including carcinoma in situ (CIS), in patients with suspected lesions or those undergoing surveillance. It is used with the Karl Storz D-Light C PDD system for Blue Light Cystoscopy as an adjunct to white light cystoscopy.

    • doxorubicin hydrochloride

      (DOXORUBICIN HYDROCHLORIDE)
      Fresenius Kabi USA, LLC
      Usage: Doxorubicin Hydrochloride Injection is indicated for treating various cancers, including leukemias, Wilms' tumor, neuroblastoma, sarcomas, and several carcinomas. It is also used as adjuvant therapy for women with axillary lymph node involvement post-primary breast cancer resection.

    • prohance

      (gadoteridol)
      Bracco Diagnostics Inc
      Usage: ProHance is indicated for magnetic resonance imaging (MRI) in adults and pediatric patients, including neonates, to visualize intracranial lesions with disrupted blood-brain barrier or abnormal vascularity, as well as lesions in extracranial/extraspinal tissues in the head and neck.